Author(s)

Piotr Materzok

Affiliation(s)

University of Wroclaw, Poland.

Corresponding Author

Piotr Materzok

ABSTRACT

Glioma represents the most frequently occurring malignant tumor of the human brain, constituting approximately 80% of all such cases. Its high malignancy, intense invasiveness, propensity for recurrence, and significant resistance to chemotherapy have significantly impacted the quality of life for patients affected by this disease. This article aims to provide a comprehensive overview of the research advancements made in understanding the mechanisms through which non-coding RNA regulates glioma's resistance to chemotherapy.

KEYWORDS

Non-coding RNA; Glioma; Chemotherapy resistance

CITE THIS PAPER

Piotr Materzok. Advancements in the study of non-coding RNA'S role in modulating glioma chemotherapy resistance. Journal of Pharmaceutical and Medical Research. 2024, 6(2): 8-10. DOI: 10.61784/jpmrv6n218.

REFERENCES

[1] Gibb EA, Enfield KS, Stewart GL. Long non-coding RNAs are expressed in oral mucosa and altered in oral premalignant lesions. Oral Oncol, 2011, 47 (11): 1055-1061.

[2] Li C, Lei B, Huang S. H19 derived microRNA-675 regulates cell proliferation and migration through CDK6 in glioma. Am J Transl Res, 2015, 7 (10): 1747-1764.

[3] Klein RH, Stephens DN, Ho H. Cofactors of LIM Domains Associate with Estrogen Receptor α to Regulate the Expression of Non-coding RNA H19 and Corneal Epithelial Progenitor Cell Function. J Biol Chem, 2016, 291 (25): 13271-13285.

[4] Yin Shi, Du Wenzhong, Jiang Chuanlu. Research progress of long non-coding RNA in glioma. Chinese Journal of Microinvasive Neurosurgery, 2016, 21 (5): 230-232.

[5] Zhang XQ, Sun S, Lam KF. A long non-coding RNA signature in glioblastoma multiforme predicts survival. Neurobiol Dis, 2013, 58: 123-131.

[6] Rabik CA, Dolan ME. Eileen Dolan. Molecular mechanisms of resis-tance and toxicity associated with platinating agents. Cancer Treat Rev, 2007, 33 (1): 9-23.

[7] Jin Peng, Zhang Qinglin. Research progress on the resistance mechanism of nitrosoureas to chemotherapy drugs in brain glioma. Shandong Medicine, 2002, 42 (21): 55-57.

[8] Yang Y, Li H, Hou S. The noncoding RNA expression profile and the effect of lncRNA AK126698 on cisplatin resistance in non - small-cell lung cancer cell. PLoS One, 2013, 8 (5): e65309.

[9] Shi SJ, Wang LJ, Yu B. LncRNA-ATB promotes trastuzumab re-sistance and invasion-metastasis cascade in breast cancer. Oncotarget, 2015, 6 (13): 11652-11663.

[10] Wang Y, Zhang D, Wu K. Long noncoding RNA MRUL pro- motes ABCB1 expression in multidrug-resistant gastric cancer cell sublines. Mol Cell Biol, 2014, 34 (17): 3182-3193.

[11] Hang Q, Sun R, Jiang C. Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expression. Anticancer Drugs, 2015, 26 (6): 632-640.

[12] Wu ZH, Wang XL, Tang HM. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer. On-col Rep, 2014, 32 (1): 395-402.